| Net Cash Provided by (Used in) Operating Activities |
-292M |
USD |
-2138% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
417M |
USD |
+4.98% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
40 |
shares |
|
Q1 2023 |
Q1 2023 |
| Common Stock, Shares, Issued |
40 |
shares |
|
Q1 2023 |
Q1 2023 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
125M |
USD |
-67.4% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
533M |
USD |
+79.9% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
500K |
USD |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
3.21M |
USD |
|
Q4 2024 |
FY 2024 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0 |
pure |
|
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Gross |
3.21M |
USD |
|
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q4 2024 |
FY 2024 |